About

What it is

Resurrect is a clinical-intelligence platform that re-reads terminated and shelved therapeutics from the public record — ClinicalTrials.gov, the FDA, the NIH, and the literature — and shows why each program stopped, how long the patents run, and who else is moving on the target, so portfolio, R&D, and business-development teams can decide faster.

Who it's for

Resurrect is for people who have to decide what to do with a stopped program.

• Pharma executives
• Researchers
• Academia
• Government

How it works

1. 1

   Read the public record

   Resurrect re-reads terminated and shelved therapeutics in ClinicalTrials.gov, FDA records, NIH records, and the literature.

2. 2

   Show what the record supports

   For each program it shows why the program stopped, how long the patents run, and who else is moving on the target. A point is cited to the record it came from. If the record does not say, the finding is marked unknown.

3. 3

   Leave the decision with the team

   Portfolio, R&D, and business-development teams use that view to decide faster. Resurrect does not make the decision for them.

What it does not do

• It does not give medical advice.
• It does not claim that any drug works, or that any drug should be approved by the FDA.
• Every finding is cited, or marked unknown.